Adapting and piloting a group intervention to address intersectional stigmas, and support shared resiliency and HIV wellness, among Black sexual minority men in Washington DC

调整和试点集体干预措施，以解决华盛顿特区黑人性少数群体的交叉耻辱问题，支持共同的弹性和艾滋病毒健康

• 批准号: 10817382
• 负责人: Alan Edward Greenberg
• 金额: $ 26.35万
• 依托单位: GEORGE WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-06-01 至 2025-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10817382
• 关键词: AIDS prevention; Achievement; Acquired Immunodeficiency Syndrome; Address; Adult; American; Area; Articulation; Automobile Driving; Award; Basic Science; Behavioral Sciences; Black race; Capital; Child; Cities; Clinical; Clinical Sciences; Collaborations; Communication; Communities; Consultations; Development; District of Columbia; Epidemic; Evaluation; Fostering; Foundations; Funding; Future; Government; Grant; Growth; HIV; HIV diagnosis; Health; Health system; Infrastructure; Institution; Investments; Lead; Leadership; Manuscripts; Medical center; Mentors; Mission; Modeling; Newly Diagnosed; Population Sciences; Positioning Attribute; Prevention; Public Health; Publishing; Reporting; Research; Research Activity; Research Personnel; Research Support; Science; Services; Site Visit; Social Sciences; Underrepresented Minority; United States Department of Veterans Affairs; United States National Institutes of Health; Universities; Update; Vision; Washington; Woman; base; black men; community engagement; comorbidity; design; epidemic response; group intervention; health data; health inequalities; high risk; implementation science; innovation; interdisciplinary approach; meetings; multidisciplinary; pre-exposure prophylaxis; programs; recruit; resilience; response; scale up; sexual minority men; social stigma; webinar; working group

OVERALL RESEARCH PLAN PROJECT SUMMARY This renewal application for the District of Columbia Center for AIDS Research (DC CFAR) presents the scientific and public health achievements of the DC CFAR to date, describes our unique citywide, multi- institutional model, underscores the strong leadership and administrative infrastructure upon which the CFAR is built and articulates a vision for our future scientific directions. The DC CFAR includes 227 HIV investigators from eight DC collaborating institutions – George Washington, Georgetown, Howard and American Universities, the Veterans Affairs Medical Center, Children's National Health System, DC Department of Health and Whitman-Walker Health. Our mission is to intensify our multi- institutional effort to promote and support research that contributes to ending the HIV epidemic in Washington, DC and beyond in partnership with government and community. Notable achievements from the previous funding period provide a strong foundation for our future, including a 46% increase in our Funded Research Base (FRB) from $11.6M in 2015 to $17.0M in 2018; over $2.8M in pilot awards granted since 2010; a 761% return on investment on completed pilot awards funded from 2010-2016; and >1,100 Core services provided and 667 HIV-related articles published by DC CFAR investigators from 2015-2019. With substantial institutional support of $2.8M over five years, and numerous scientific and programmatic innovations underway, the DC CFAR is well-positioned to respond to the critical challenges of our local epidemic. The Specific Aims of the DC CFAR are to: Aim 1: Provide scientific leadership and institutional infrastructure to advance HIV research among the eight collaborating DC CFAR institutions; Aim 2: Stimulate and support innovative and consequential HIV research in the basic, clinical, prevention and social and behavioral sciences while promoting an interdisciplinary approach to addressing the NIH high priority scientific HIV focus areas; Aim 3: Drive the development and recruitment of early stage, new, and women and underrepresented minority HIV investigators; and Aim 4: Enhance communication and foster meaningful new collaborations between DC CFAR investigators and academic, government, community and clinical partners. To achieve these aims, the DC CFAR supports five Cores: Administrative to provide scientific leadership and fiscal oversight; Developmental to oversee the pilot awards and mentoring programs; and Basic Sciences, Clinical and Population Sciences, and Social and Behavioral Sciences to provide services to support innovative and multi-disciplinary HIV research. Lastly, the DC CFAR supports two Scientific Working Groups – HIV Cure and the Ending the HIV Epidemic – to galvanize research in these high priority areas.

总体研究计划 项目摘要 哥伦比亚特区艾滋病研究中心（DC CFAR）的续签申请表明 迄今 机构模型强调了CFAR的强大领导和行政基础设施 建造并阐明了我们未来的科学方向的愿景。 DC CFAR包括来自八个DC合作机构的227名HIV调查人员 - 乔治·华盛顿， 乔治敦，霍华德和美国大学，退伍军人事务医疗中心，儿童国家 卫生系统，华盛顿特区卫生部和惠特曼·沃克卫生部。我们的使命是加强我们的多 机构努力促进和支持有助于终止华盛顿的艾滋病毒流行的研究 DC及以后与政府和社区合作。以前的显着成就 资金期为我们的未来奠定了坚实的基础，包括我们资助的研究增加了46％ 基本（FRB）从2015年的1,160万美元到2018年的1700万美元；自2010年以来，授予超过280万美元的飞行员奖； 761％ 2010 - 2016年资助的已完成的飞行员奖的投资回报；和> 1,100个核心服务 DC CFAR研究人员于2015 - 2019年发表了667篇与HIV相关的文章。 在五年内获得280万美元的机构支持，以及许多科学和程序化 创新正在进行中，DC CFAR的姿势很好，以应对我们当地的关键挑战 流行性。 DC CFAR的具体目的是： 目标1：提供科学领导和机构基础设施，以推动艾滋病毒研究 八个合作的DC CFAR机构； 目标2：刺激和支持基本，临床中的创新和相应的HIV研究 预防，社会和行为科学，同时推广跨学科的方法 解决NIH高优先级科学艾滋病毒焦点领域； 目标3：推动早期，新妇女的发展和招募以及人为不足 少数艾滋病毒研究者；和 目标4：增强沟通并促进DC CFAR之间有意义的新合作 研究人员和学术，政府，社区和临床伙伴。 为了实现这些目标，DC CFAR支持五个核心：行政人员提供科学领导和 财政监督；开发监督飞行员奖和心理计划；和基本科学， 临床和人口科学以及社会和行为科学，以提供支持 创新和多学科的艾滋病毒研究。最后，DC CFAR支持两个科学工作组 - 艾滋病毒治愈和终结艾滋病毒流行 - 在这些高优先级领域的研究。